Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

HIV Status Not Grounds For Denying People Professional Licenses, Federal Officials Say
The Department of Justice on Thursday said that it is a violation of the Americans with Disabilities Act to bar people -- such as barbers, masseuses, and home health care aides -- from receiving professional licenses or training at occupational schools because they have HIV or AIDS, the AP/Los Angeles Times reports. Some states, for example, require that cosmetologists be free of communicable diseases. "The government says that type of regulation is outdated and was not intended to bar people with HIV. The original goal of such a rule was to prevent the spread of tuberculosis and other diseases, not prevent people with [HIV] from working in certain fields," according to the AP/Times. Furthermore, "The Supreme Court has found people with AIDS or HIV are covered under the law barring discrimination against people with disabilities," the article states (7/16).
generic viagra online
2009 Annual Gates Award For Global Health Won By LSHTM
The London School of Hygiene & Tropical Medicine has won the Gates Award for Global Health, and will receive $1 million in prize money. Purchase zoloft to treat depression.
News of the day
Data Suggests Proton Pump Inhibitors Can Induce Acid-Related Symptoms In Healthy Adults
Treatment with proton pump inhibitors (PPIs) for eight weeks induces acid-related symptoms like heartburn, acid regurgitation and dyspepsia once treatment is withdrawn in healthy individuals, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
Diagnostics

Comparative Effectiveness Necessary To Weigh New Drugs Against Old Ones, Opinion Piece Says

Patients and physicians "need to know not just whether a new drug outperforms a placebo, but whether it"s a real advance on what"s already on the market," Richard Friedman, a professor of psychiatry at Weill Cornell Medical College, writes in a New York Times opinion piece. According to Friedman, "Doctors and patients alike are inundated by drug company marketing." Friedman states he has seen "scores of patients" who are "eager to get the latest antidepressant or mood stabilizer that promised them tranquility on their TV screens." He continues that these new treatments are not necessarily better than older, proven treatments. Comparative effectiveness research would allow "head-to-head trials comparing new and standard treatments," which is why the practice has "provoked strong resistance from the makers of drugs and devices who fear that their fancy new products may not be any better than current ones," according to Friedman. He concludes, "I"d opt for an old drug with a known track record of efficacy and safety over an expensive newcomer with no added benefit -- any day of the week" (Friedman, New York Times, 5/19). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009